Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06968169 · ClinicalTrials.gov registry record · NA
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
A NA study of Healthy Subjects and Developmental Language Disorder, sponsored by Father Flanagan's Boys' Home.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06968169: Recruiting NA study of Healthy Subjects and Developmental Language Disorder, sponsored by Father Flanagan's Boys' Home.
NCT06968169 is a NA study of Healthy Subjects and Developmental Language Disorder that is actively recruiting participants, run by Father Flanagan's Boys' Home. The registered enrollment target is 120 participants, roughly in line with the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06968169, a NA study of Healthy Subjects and Developmental Language Disorder, is actively recruiting participants, sponsored by Father Flanagan's Boys' Home.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine how memory and attention affect the ability of children with developmental language disorder (DLD) to learn and use new vocabulary.
Primary Outcome
Number of syllables pronounced correctly.
Conditions Studied
Interventions
- BEHAVIORAL Supportive learning
- BEHAVIORAL Cascades
Study Locations (1)
Nebraska
- Boys Town National Research Hospital - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-02-09 |
| Est. Completion | 2030-06 |
| Phase | NA |
What NCT06968169 shows while recruiting
NCT06968169 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target.
The record links to 2 conditions, with Healthy Subjects appearing as the primary indexed condition, and to 2 interventions - of which Supportive learning is the first listed.
NCT06968169 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT06968169 about?
NCT06968169 is a clinical study titled "The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder". The goal of this clinical trial is to determine how memory and attention affect the ability of children with developmental language disorder (DLD) to learn and use new vocabulary.
What is the current status of trial NCT06968169?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-02-09. Estimated completion is 2030-06.
What conditions does trial NCT06968169 study?
This clinical trial studies the following conditions: Healthy Subjects, Developmental Language Disorder.
What interventions are being tested in trial NCT06968169?
The interventions under investigation include: Supportive learning (BEHAVIORAL), Cascades (BEHAVIORAL).
Who is sponsoring clinical trial NCT06968169?
This trial is sponsored by Father Flanagan's Boys' Home, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06968169 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06968169's enrollment target sits among peer trials
120 12th of 69 higher than 58 of 69 other Healthy Subjects trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
Echography Study_Anthropometric Measurements
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
RECRUITING · NA
-
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
RECRUITING · NA
-
Cerebral Cortical Influences on Autonomic Function
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI